Addison Disease: Clinical Trials

36 trials for Addison Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 5 recruiting, 5 unknown, 2 not yet recruiting. 11 Not applicable, 8 Phase 2, 5 Phase 4, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 4, Not yet recruiting 2, Recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1
Phase 28Completed 6, Terminated 1, Unknown 1
Phase 45Completed 4, Unknown 1
Phase 33Completed 3
Phase 11Completed 1

Follow Addison Disease: new trials by email Literature Review of Addison Disease trials Research Report on Addison Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Telehealth Music Therapy for Adults With Endocrine Disorder and Depression
Telehealth Resource Oriented Music Therapy - Type 1 Diabetes, Hashimoto Disease
Not applicableRecruitingAppalachian State University102026-07-162026-07-30
Risks of Ramadan Fasting in Patients With Primary Adrenal Insufficiency Treated With Prednisolone.
Ramadan fasting - Primary Adrenal Insufficiency, Ramadan Fasting
Not applicableNot yet recruitingHopital La Rabta352026-01-222026-01-26
SPL Insufficiency Syndrome (SPLIS)/NPHS14: a SPLIS Observational Study and Patient Registry (International)
no intervention - Sphingolipidoses, Enzyme Deficiency
RecruitingUniversity of California, San Francisco1202025-04-222025-10-24
Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
no intervention - Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
RecruitingUniversity of California, San Francisco282025-04-222026-08-04
Growing up With the Young Endocrine Support System (YESS!)
YESS! game, Snake '97, Transition-toolkit - Congenital Adrenal Hyperplasia, Hypogonadotropic Hypogonadism
Not applicableNot yet recruitingdr. Laura C. G. de Graaff-Herder1602024-12-012023-09-07
Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency
intermittent fasting - Primary Adrenal Insufficiency, Intermittent Fasting
Not applicableCompletedHopital La Rabta302024-03-042025-02-14
Does Relative Hypoglycaemia &/or Sleep Disturbance Contribute to the Lethargy Observed in Addison's Disease
Blood test - Addison Disease
UnknownThe Leeds Teaching Hospitals NHS Trust302022-04-072023-07-17
The Effects of Two Brands of Hydrocortisone Injected Intramuscularly Into Deltoid and Thigh Muscles
Solu-Cortef 100 MG Injection, Hydrocortisone 100mg/ml - Addison's Disease
Phase 4UnknownThe London Clinic82022-03-142022-04-27
Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency
Chronocort, Plenadren - Primary Adrenal Insufficiency
Phase 2CompletedNeurocrine UK Limited582021-11-232026-09-14
Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up
No intervention. - Type 1 Diabetes, Autoimmune Diseases
UnknownCentral Hospital, Nancy, France2502021-03-152021-03-30
A Study of Markers of Glucocorticoid Effects in Patients With Addisons Disease (DOSCORT)
Betamethasone - Addison Disease
Phase 4CompletedGöteborg University302021-03-022025-04-24
Screening and Stimulation Testing for Residual Secretion of Adrenal Steroid Hormones in Autoimmune Addison's Disease
Cosyntropin stimulation test, Baseline blood tests, 30-hour ambulatory sampling of intestinal fluid - Primary Adrenal Insufficiency
Not applicableActive not recruitingUniversity of Bergen2002018-09-262026-05-08
Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders
circadian gene expression evaluation - Cushing Syndrome, Adrenal Insufficiency
Not applicableRecruitingUniversity of Roma La Sapienza442018-07-042026-10-20
Vaginal Prednisone Administration for Prevention of Adrenal Crisis
100mg prednisone suppository - Adrenal Insufficiency
Phase 2CompletedWuerzburg University Hospital122017-01-012017-06-20
Biomarker(s) for Glucocorticoids
Hydrocortisone, Placebo - Addison Disease
Not applicableCompletedVastra Gotaland Region112014-05-012021-04-12
Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia
Solu-Cortef, Cortef - Addison Disease, Adrenal Hyperplasia Congenital
Phase 1 / Phase 2CompletedHaukeland University Hospital82014-03-272024-06-07
Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)
Plenadren, Conventional glucocorticoid therapy - Primary Adrenal Insufficiency, Secondary Adrenal Insufficiency
Phase 4CompletedUniversity of Roma La Sapienza892014-03-012019-04-25
Cardiovascular Status in Adrenal Insufficiency
Cardiovascular evaluation - Adrenal Insufficiency
CompletedWuerzburg University Hospital682013-08-012018-02-08
Effect of Cortisol on Physical Exertion in Patients With Primary Adrenal Failure
Hydrocortisone - Addison Disease
Phase 2UnknownHaukeland University Hospital202013-06-012013-12-02
Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes
Cortef, Solu-cortef - Addison Disease, Type 1 Diabetes
Phase 2TerminatedHaukeland University Hospital42013-04-242024-03-01

Showing 20 of 36. Sign in to see all of them.

Narrower conditions

Adrenal Insufficiency (9)  ·  Diabetes Mellitus, Type 1 (5)  ·  Adrenal Hyperplasia, Congenital (3)  ·  Graves Disease (3)  ·  Hashimoto Disease (3)  ·  Celiac Disease (2)  ·  Dehydration (2)  ·  Endocrine System Diseases (2)  ·  Hypoglycemia (2)  ·  Liver Cirrhosis, Biliary (2)  ·  Myasthenia Gravis (2)  ·  Nephrotic Syndrome (2)  ·  Obesity (2)  ·  Rare Diseases (2)

Broader conditions

Adrenal Gland Diseases (36)  ·  Immune System Diseases (35)  ·  Autoimmune Diseases (34)  ·  Endocrine System Diseases (34)  ·  Adrenal Insufficiency (27)  ·  Nutritional and Metabolic Diseases (15)  ·  Metabolic Diseases (13)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Glucose Metabolism Disorders (7)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Genetic Diseases, Inborn (6)  ·  Male Urogenital Diseases (6)  ·  Metabolism, Inborn Errors (6)

Interventions

Hydrocortisone (11)  ·  hydrocortisone hemisuccinate (4)  ·  Hematologic Tests (2)  ·  Betamethasone (1)  ·  Cortisone (1)  ·  Cosyntropin (1)  ·  Dehydroepiandrosterone (1)  ·  Ergometry (1)  ·  Etomidate (1)  ·  Glycyrrhiza glabra extract (1)  ·  Injections (1)  ·  Prednisone (1)  ·  Propofol (1)  ·  Sodium Chloride (1)  ·  Solvents (1)

Sponsors

Haukeland University Hospital (5)  ·  Hopital La Rabta (2)  ·  University of California, San Francisco (2)  ·  University of Roma La Sapienza (2)  ·  University of Wuerzburg (2)  ·  Wuerzburg University Hospital (2)  ·  Appalachian State University (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Bruno Allolio (1)  ·  Central Hospital, Nancy, France (1)  ·  Göteborg University (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Mayo Clinic (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Neurocrine UK Limited (1)

Countries

Germany (6)  ·  Norway (6)  ·  United States (6)  ·  United Kingdom (5)  ·  Sweden (4)  ·  France (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Switzerland (2)  ·  Tunisia (2)  ·  Australia (1)  ·  Belgium (1)  ·  Spain (1)

Top investigators

Bruno Allolio, MD (2)  ·  Julie D Saba, MD, PhD (2)  ·  Stefanie Hahner, MD (2)  ·  Andrea M Isidori, MD, PhD (1)  ·  Anna G Nilsson, MD, PhD (1)  ·  Ernst A Lien, Prof. MD. (1)  ·  Eystein Husebye, Professor (1)  ·  Eystein S Husebye, M.D, Prof (1)  ·  Eystein S Husebye, Prof, MD (1)  ·  Felix G Riepe, MD (1)  ·  Gudmundur Johannsson, Prof., MD (1)  ·  Gudmundur Johannsson, Professor (1)  ·  Katerina Simunkova, MD, PhD (1)

Results publications

PMID 17684047, PMID 19383806, PMID 22112807, PMID 23672956, PMID 24170102, PMID 24944332, PMID 26914224, PMID 29129244, PMID 29229498, PMID 29618670, PMID 29846607, PMID 31853550, PMID 32392298, PMID 32419166, PMID 33236103, PMID 33821793, PMID 34213700, PMID 36042975, PMID 37172949, PMID 38053731, PMID 41108503, PMID 41552007, PMID 42824572

NIH funding

2009 (3), 2016 (1), R01HD113778 (1)